Medgenics announced Director entered into stock trading plan & change of adviser
(MDGN) : Co announced that, on 23 December 2013, Andrew Pearlman, founder and a director, has established a personal stock trading plan in accordance both with the guidelines established by Rule 10b5-1 under the U.S. Securities Exchange Act of 1934, as amended, and the AIM Rules for Companies as well as the Company's policies with respect to insider sales. The transactions under the plan will be disclosed publicly through Form 144 and Form 4 filings as required by the U.S. Securities and Exchange Commission and in the UK through a Regulatory Information Service.
